Comparison of the Effect of Ciprofloxacin and Nalidixic Acid in the Infection of Different Parts of the Urinary Tract

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 29

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJHS-4-2_008

تاریخ نمایه سازی: 29 بهمن 1402

چکیده مقاله:

Background: Urinary tract infection (UTI) is one of the most common bacterial infections. The most common cause is Escherichia coli. This research is done with the aim at compare effect of ciprofloxacin with nalidixic acid in the infection of different parts of the urinary tract.Methods: In this cross-sectional study, ۱۳۰ patients with symptoms of the urinary tract infection referred to Imam Hossain Hospital of Shahrood were studied. For the all patients, urine samples were collected by standard method and urine analysis and culture was performed. Then, positive culture samples were tested by antibiogram and the resistance rate for the two antibiotics ciprofloxacin and nalidixic acid and MBC and MIC was investigated.Results: Of the ۱۳۰ patients with symptoms of UTI (fever, flank pain or tenderness and dysuria, urgency or frequency (۸۴ patients had positive urine culture. Of all patients with positive urine, ۳۱ cases had symptoms of pyelonephritis, ۲۵ patients had symptoms of cystitis and ۲۸ patients had symptoms of UTI. In antibiogram for positive urine samples, ۲۱ pieces were resistant to ciprofloxacin and ۴۶ pieces were resistant to nalidixic acid which significantly reduced resistance to ciprofloxacin (P=۰.۰۰۵). There was no significant difference between the two antibiotics in place of clinical symptoms and drug resistance. So there was no significant difference between the two MIC and MBC in place of clinical symptoms and drug resistance.Conclusions: This study showed that ciprofloxacin is more effective in controlling infection of different parts of the urinary tract due to less drug resistance.Background: Urinary tract infection (UTI) is one of the most common bacterial infections. The most common cause is Escherichia coli. This research is done with the aim at compare effect of ciprofloxacin with nalidixic acid in the infection of different parts of the urinary tract. Methods: In this cross-sectional study, ۱۳۰ patients with symptoms of the urinary tract infection referred to Imam Hossain Hospital of Shahrood were studied. For the all patients, urine samples were collected by standard method and urine analysis and culture was performed. Then, positive culture samples were tested by antibiogram and the resistance rate for the two antibiotics ciprofloxacin and nalidixic acid and MBC and MIC was investigated. Results: Of the ۱۳۰ patients with symptoms of UTI (fever, flank pain or tenderness and dysuria, urgency or frequency (۸۴ patients had positive urine culture. Of all patients with positive urine, ۳۱ cases had symptoms of pyelonephritis, ۲۵ patients had symptoms of cystitis and ۲۸ patients had symptoms of UTI. In antibiogram for positive urine samples, ۲۱ pieces were resistant to ciprofloxacin and ۴۶ pieces were resistant to nalidixic acid which significantly reduced resistance to ciprofloxacin (P=۰.۰۰۵). There was no significant difference between the two antibiotics in place of clinical symptoms and drug resistance. So there was no significant difference between the two MIC and MBC in place of clinical symptoms and drug resistance. Conclusions: This study showed that ciprofloxacin is more effective in controlling infection of different parts of the urinary tract due to less drug resistance.

نویسندگان

Ehsan Binesh ۱

۱. Department of Infectious, Imam Hossain Center for Education, Research and Treatment, Shahroud University of Medical Sciences, Shahroud, Iran.

Mehdi Mirzaii ۲

۲. Department of Microbiology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

Fateme Asadi ۳

۳. Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

Pouneh Zolfaghari ۴

۴. Vice-chancellery of Health, Shahroud University of Medical Sciences, Shahroud, Iran.

Mohammad Bagher Sohrabi ۵

۵. School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. ...
  • Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated ...
  • Mitchell BG, Fasugba O, Beckingham W, Bennett N, Gardner A. ...
  • Howard DH, Scott RD 2nd, Packard R, Jones D. The ...
  • Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, ...
  • Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. ...
  • Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, ...
  • Perrin M, Donnio PY, Heurtin-Lecorre C, Travert MF, Avril JL. ...
  • Wilson ML, Gaido L. Laboratory Diagnosis of Urinary Tract Infections ...
  • Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and ...
  • Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of ...
  • Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, ...
  • Cheng AC, Turnidge J, Collignon P, Looke D, Barton M, ...
  • Wang Y, Zhao S, Han L, Guo X, Chen M, ...
  • Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance ...
  • Sannes MR, Kuskowski MA, Johnson JR. Geographical distribution of antimicrobial ...
  • Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance ...
  • Bergman M, Nyberg ST, Huovinen P, Paakkari P, Hakanen AJ, ...
  • Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC ...
  • Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M. ...
  • Bouchillon SK, Badal RE, Hoban DJ, Hawser SP. Antimicrobial susceptibility ...
  • Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, ...
  • Swami SK, Liesinger JT, Shah N, Baddour LM, Banerjee R. ...
  • Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, ...
  • Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. ...
  • Freeman JT, Anderson DJ, Sexton DJ. Seasonal peaks in Escherichia ...
  • Sun L, Klein EY, Laxminarayan R. Seasonality and temporal correlation ...
  • Adam HJ, Baxter MR, Davidson RJ, Rubinstein E, Fanella S, ...
  • Cornaglia G, Hryniewicz W, Jarlier V, Kahlmeter G, Mittermayer H, ...
  • نمایش کامل مراجع